the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Cai Jian qiang
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Principal Investigator - Zhou Ai ping, professor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, China
Recruiting - Huizhou Central People'S Hospital
Guandong, China
Recruiting - Jinan Central Hospital
Shandong, China
Recruiting - Linyi Cancer Hospital
Shandong, China
Recruiting - Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center
Shenzhen, China
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 11 Nov 2022
- Primary completion
- 1 Aug 2025
- Completion
- 1 Aug 2026
- Last update posted
- 10 Mar 2023
- Registered enrollment
- 576
- Registry id
- NCT05408221
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.